NGM BIOPHARMACEUTICALS INC (NGM)
US62921N1054 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -142.38M | -162.67M | -120.34M | -102.49M | -42.80M | |||
| Depreciation Amortization | 2.22M | 4.04M | 6.09M | 6.56M | 7.61M | |||
| Change In Working Capital | -18.38M | -20.71M | 4.21M | -3.70M | -17.94M | |||
| Other non cash items | 26.33M | 34.91M | 36.81M | 16.14M | 11.96M | |||
| OPERATING CASH FLOW | -132.20M | -144.44M | -73.23M | -83.50M | -41.17M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.25M | -1.86M | -1.68M | -1.88M | -3.49M | |||
| Other Investing Activity | 115.54M | 16.18M | -69.97M | -49.12M | 52.21M | |||
| INVESTING CASH FLOW | 114.29M | 14.32M | -71.65M | -51.00M | 48.72M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 1.77M | 54.23M | 149.66M | 36.15M | 180.75M | |||
| Other Financing Activity | N/A | 0.00 | 0.00 | -610.00K | N/A | |||
| FINANCING CASH FLOW | 1.77M | 54.23M | 149.66M | 35.54M | 180.75M | |||
| CHANGE IN CASH | -16.14M | -75.89M | 4.78M | -98.96M | 188.30M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -132.20M | -144.44M | -73.23M | -83.50M | -41.17M | |||
| Capital Expenditure | -1.25M | -1.86M | -1.68M | -1.88M | -3.49M | |||
| FREE CASH FLOW | -133.45M | -146.30M | -74.91M | -85.38M | -44.66M | |||
All data in USD